Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lifeist Wellness Inc V.LFST

Alternate Symbol(s):  LFSWF

Lifeist Wellness Inc. is a Canada-based health-tech company. The Company's portfolio of wellness companies leverages advancements in science and technology to enable consumers to find their individual path to wellness. Its portfolio business units include Mikra, which is a biosciences and consumer wellness company developing and selling products for cellular health and CannMart, which is a business-to-business (B2B) wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards.


TSXV:LFST - Post by User

Post by QuothTheRavenon Jun 07, 2021 1:33pm
109 Views
Post# 33341082

Latest PR about CannMart Labs Dealer's License

Latest PR about CannMart Labs Dealer's License
That's pretty major.  I didn't even know N was aiming at anything past mushrooms.  But really nice -- the more products the better!

[url=https://ceo.ca/@nasdaq/namaste-technologies-provides-corporate-update-on-cannmart]https://ceo.ca/@nasdaq/namaste-technologies-provides-corporate-update-on-cannmart[/url]
 
"Namaste is pleased to advise that it's wholly owned subsidiary CannMart Labs Inc. has submitted its application for a Health Canada Controlled Drugs and Substances Dealer’s Licence for future storage and distribution of the following controlled substances: psilocybin, psilocin, ketamine, LSD, DMT and MDMA. Projected timeline for receipt of approvals is by the beginning of fiscal third quarter of 2022. Subject to Health Canada acceptance, the Dealer’s Licence will allow Labs to sell these controlled substances to individuals (or their compounding pharmacies), researchers and companies undertaking clinical trials, each retaining appropriate approvals for such possession and use."
<< Previous
Bullboard Posts
Next >>